A device that analyzes blood levels of prostate-specific antigen (PSA) is one of the first doctor’s-office uses of microfluidics–technology that can manipulate fluids on a chip at microscopic scales. When a cartridge bearing a blood sample is inserted into the tabletop device, an accurate reading can be completed in 15 minutes, helping monitor the health of patients with prostate cancer. The procedure used now involves sending a sample to a lab for analysis, which often takes a day or two. The device received European approval in June.
Credit: Christopher Harting
Product: Claros DX 1
Cost: To be announced in late 2010
Availability: Late 2010 in selected European markets
Other products in this section:
Be the leader your company needs. Implement ethical AI.
Join us at EmTech Digital 2019.
Want to know when you’re going to die?
Your life span is written in your DNA, and we’re learning to read the code.
White-people-only DNA tests show how unequal science has become
Companies are selling disease-risk tests that only work in people of European ancestry. They hope to fix that soon.
Genes linked to being gay may help straight people get more sex
The largest-ever study of genetics and sexual orientation offers a theory about the longevity of genes that influence homosexuality.